# Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

> **NCT01390610** · — · COMPLETED · sponsor: **HealthPartners Institute** · enrollment: 27 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetic Blood Glucose Monitoring

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01390610
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390610, "Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01390610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*